There are some proposed changes to the Medicare Shared Savings Program (MSSP) that may be favorably or not depending on the accountable care organization (ACO) and its situation, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
There are some proposed changes to the Medicare Shared Savings Program (MSSP) that may be favorably or not depending on the accountable care organization (ACO) and its situation, said Allison Brennan, MPP, senior vice president of government affairs for the National Association of ACOs.
Transcript
What are some proposed changes to the MSSP that some ACOs might see as an opportunity, but others might view as a challenge?
There’s a lot of complexity in this program, and as we look at the impact of certain proposals on various ACOs it can affect ACOs differently. So, a good example of this is benchmarking, where we see a proposal that would change how CMS incorporates a component of regional expenditure data into the benchmark. And the goal of that policy is to avoid comparing ACOs only to their historical performance as times moves on.
And this is something that we’re very supportive of—moving away from just looking at those historical expenditures. If we remain just looking at historical expenditures, eventually they’ll get so low that people can’t achieve savings and always beat their past performance. So, a way to fix that problem is to increasingly compare ACOs to other providers in their region. Some of the proposals in the benchmark change how CMS would incorporate that regional comparison into the benchmark. So, certain ACOs may view that favorably and other ACOs may not view it favorably, depending on how they compare to their regional costs.
Another example is risk adjustment. We are definitely pleased to see some of the proposals CMS put forward with risk adjustment. But some of the other elements of the proposal will be harmful to certain ACOs, so, we’re making some recommendations for CMS to finalize some of elements of the risk adjustment proposals and then modify other elements.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Addressing Financial Aid and Patient Independence as Part of Atopic Dermatitis Care
March 13th 2025Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition were emphasized at this year’s 2025 American Academy of Dermatology meeting.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More